Primary Site >> Pancreatic Cancer
Gene >> ABCB1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. PMID: 7914421 Ref: Multidrug-resistance gene (mdr1) expression in human tumor xenografts. PMID: 21559711 |
Ref: Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. PMID: 8766529 |
Ref: Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer. PMID: 11039467 |
Ref: Mechanisms of taxotere-related drug resistance in pancreatic carcinoma. PMID: 11469885 Ref: Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. PMID: 11854916 |
Ref: Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). PMID: 12804765 |
Ref: Detection of multidrug resistant gene 1 in pancreatic cancer. PMID: 15138133 |
Ref: Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. PMID: 15688370 Ref: P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine. PMID: 16195770 |
Ref: Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes. PMID: 17645459 Ref: MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. PMID: 17695494 Ref: [Significance and reversal of MDR1/P-gp in pancreatic cancer chemotherapy]. PMID: 18275717 |
Ref: Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells. PMID: 17714734 Ref: Persistence of side population cells with high drug efflux capacity in pancreatic cancer. PMID: 18240351 |
Ref: ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. PMID: 19077464 Ref: Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152. PMID: 19188929 Ref: CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. PMID: 19598259 Ref: Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy. PMID: 19887556 |
Ref: The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors. PMID: 20127092 Ref: Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. PMID: 20335952 Ref: [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. PMID: 21054984 |
Ref: Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. PMID: 20922799 Ref: Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics. PMID: 21282407 Ref: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PMID: 21304978 Ref: Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. PMID: 21566063 |
Ref: Single nucleotide polymorphism of multidrug-resistance 1 and anti- multidrug-resistance 1 single chain antibody treatment for the pancreatic cancer cell line. PMID: 21940367 Ref: Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. PMID: 21956451 Ref: Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism analysis. PMID: 22155850 Ref: Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1alpha and P-gp in the human pancreatic carcinoma cell line PANC-1. PMID: 22367292 Ref: Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. PMID: 22846052 |
Ref: CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. PMID: 23036582 Ref: Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. PMID: 23188630 Ref: CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2. PMID: 23463283 Ref: Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. PMID: 23525071 Ref: MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. PMID: 23774063 Ref: Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes. PMID: 24069258 |
Ref: Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer. PMID: 24288256 Ref: Cyclin D1 amplification in multiple myeloma is associated with multidrug resistance expression. PMID: 24468132 Ref: miRNAs for the detection of multidrug resistance: overview and perspectives. PMID: 24786846 Ref: ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance? PMID: 24883056 Ref: Interrogation of multidrug resistance (MDR1) P-glycoprotein (ABCB1) expression in human pancreatic carcinoma cells: correlation of 99mTc-Sestamibi uptake with western blot analysis. PMID: 25036383 Ref: Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. PMID: 25224651 Ref: Effects of hypoxia-inducible factor-1alpha silencing on drug resistance of human pancreatic cancer cell line Patu8988/5-Fu. PMID: 25699390 |
Ref: Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis. PMID: 25481101 Ref: TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. PMID: 26709920 |
Ref: Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. PMID: 26684804 Ref: Expression of the bitter receptor T2R38 in pancreatic cancer: localization in lipid droplets and activation by a bacteria-derived quorum-sensing molecule. PMID: 26862855 Ref: 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016. PMID: 27090254 |
Ref: Leptin-Notch signaling axis is involved in pancreatic cancer progression. PMID: 27999190 Ref: Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture. PMID: 28099906 Ref: GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts. PMID: 28741686 |
Ref: Detection and proteomic characterization of extracellular vesicles in human pancreatic juice. PMID: 29550476 |